Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
At 50, focusing on the right investments is essential. Learn which options can help you achieve your retirement goals.
19,777 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
MSCI stock is facing a sharp move lower after quarterly results and an strategic shift. This article explains the dri...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Saluda Grade taps Patrick Lo to join co-CIO leadership and broaden its asset-based finance platform. The move positio...
A single calendar day could push the market in surprising directions. This article explains why Feb 26 matters for AI...
A public clash within the GOP erupts as Marjorie Taylor Green accuses Trump of placing a donor class above America Fi...
Molson Coors shares fell sharply after a disappointing quarter and a formal downgrade from a major bank. This article...
Markets are volatile, but corrections can reset prices, boost disciplined investing, and strengthen long-term strateg...
Nvidia’s Jens en Huang just signaled a potential pivot into software stocks as AI optimism hits a softer patch. This ...